scispace - formally typeset
J

Julene K. Johnson

Researcher at University of California, San Francisco

Publications -  115
Citations -  11425

Julene K. Johnson is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Dementia & Cognition. The author has an hindex of 35, co-authored 105 publications receiving 9803 citations. Previous affiliations of Julene K. Johnson include University of California & University of Texas at Dallas.

Papers
More filters
Journal ArticleDOI

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia.

TL;DR: The revised criteria for behavioural variant frontotemporal dementia improve diagnostic accuracy compared with previously established criteria in a sample with known frontotmporal lobar degeneration and reflect the optimized diagnostic features, less restrictive exclusion features and a flexible structure that accommodates different initial clinical presentations.
Journal ArticleDOI

Cognition and Anatomy in Three Variants of Primary Progressive Aphasia

TL;DR: Cognitive, genetic, and anatomical features indicate that different PPA clinical variants may correspond to different underlying pathological processes.
Journal ArticleDOI

Frontotemporal dementia: clinicopathological correlations.

TL;DR: This study assessed whether specific clinical features predict the underlying pathology of Frontotemporal lobar degeneration, and found that both clinical features and underlying pathology are related.
Journal ArticleDOI

Distinctive neuropsychological patterns in frontotemporal dementia, semantic dementia, and Alzheimer disease.

TL;DR: The neuropsychological profiles highlight the distinctiveness between the 3 syndromes, are consistent with the known loci of neuropathology in these conditions, and can potentially serve as an adjunct to the current clinical criteria.
Journal ArticleDOI

Clinical and Pathological Evidence for a Frontal Variant of Alzheimer Disease

TL;DR: A subgroup of patients with pathologically confirmed AD who presented in the early stages of dementia with disproportionate impairments on tests of frontal lobe functioning and had a greater-than-expected degree of NFT pathology in the frontal lobes is identified, suggesting the existence of a frontal variant of AD that has distinctive clinical and pathological features.